Search
for
Sort by
Research 31–60 of 664
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Modelling of the composition of emulsion medicines and cosmetics stabilized by a biocomplex of surfactant substances based on rhamnolipids Pseudomonas sp. PS-17
- Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men
- Total prostate volume as risk factor for semen pathologies in ageing male
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- A genetic test for androgenetic alopecia: polymorphisms in the androgen receptor gene provide a genetic screening test for androgenetic alopecia and earlier medical intervention
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Level-1 Data From the REDUCE Study and the PCPT Data
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Is there a relationship between androgenic alopecia and benign prostatic hyperplasia?
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Farmácia Azevedo Carvalho, Cabeceiras de Bastos
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- Hair, Hormones, and High-Risk Prostate Cancer
- Prostatakarzinom